Área Sanitaria de Pontevedra e O Salnés
Área sanitaria
Universidade da Coruña
La Coruña, EspañaPublicacións en colaboración con investigadores/as de Universidade da Coruña (63)
2024
-
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Alimentary Pharmacology and Therapeutics
2023
-
Brief Training of Technical Bleeding Control Skills—A Pilot Study with Security Forces
International Journal of Environmental Research and Public Health, Vol. 20, Núm. 3
-
Cognitive impairment and dementia in young onset Parkinson’s disease
Journal of Neurology, Vol. 270, Núm. 12, pp. 5793-5812
-
Overexpression of E-Cadherin Is a Favorable Prognostic Biomarker in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis
Biology, Vol. 12, Núm. 2
-
Predictive value of CDKN2A/p16INK4a expression in the malignant transformation of oral potentially malignant disorders: Systematic review and meta-analysis
Pathology Research and Practice, Vol. 248
-
The interaction between liver cirrhosis, infection by Streptococcus bovis, and colon cancer
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 7, pp. 907-912
2022
-
Biologic therapy in refractory neurobehçet's disease: a multicentre study of 41 patients and literature review
Rheumatology (Oxford, England), Vol. 61, Núm. 11, pp. 4427-4436
-
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)
Journal of Clinical Medicine
-
Evaluation of contingency plans in the care of patients in intensive care units in the COVID-19 pandemic
Journal of Healthcare Quality Research, Vol. 37, Núm. 5, pp. 291-298
-
Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors
Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 245-252
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Motor Fluctuations Development Is Associated with Non-Mostor Symptoms Burden Progression in Parkinson’s Disease Patients: A 2-Year Follow-Up Study
Diagnostics, Vol. 12, Núm. 5
-
Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study
Gastroenterologia y Hepatologia, Vol. 45, Núm. 5, pp. 342-349
-
Oral Chronic Hyperplastic Candidiasis and Its Potential Risk of Malignant Transformation: A Systematic Review and Prevalence Meta-Analysis
Journal of Fungi, Vol. 8, Núm. 10
-
Survival outcomes in laryngeal chondrosarcoma: a systematic review
Acta Otorhinolaryngologica Italica, Vol. 42, Núm. 6, pp. 502-515
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
-
Vortioxetine Improves Depressive Symptoms and Cognition in Parkinson’s Disease Patients with Major Depression: An Open-Label Prospective Study
Brain Sciences, Vol. 12, Núm. 11
2021
-
COVID-19 pneumonia in Galicia (Spain): Impact of prognostic factors and therapies on mortality and need for mechanical ventilation
PLoS ONE, Vol. 16, Núm. 6 June
-
Cutaneous adverse events in patients receiving anticancer therapy in a tertiary hospital setting: the old and the new
International Journal of Dermatology, Vol. 60, Núm. 2, pp. 208-216
-
Depression is Associated with Impulse-compulsive Behaviors in Parkinson's disease: Impulse-compulsive Behaviors and Depression in PD
Journal of Affective Disorders, Vol. 280, pp. 77-89